G. Schönbeck

494 total citations
19 papers, 325 citations indexed

About

G. Schönbeck is a scholar working on Pharmacology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, G. Schönbeck has authored 19 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Psychiatry and Mental health and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in G. Schönbeck's work include Treatment of Major Depression (5 papers), Schizophrenia research and treatment (4 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). G. Schönbeck is often cited by papers focused on Treatment of Major Depression (5 papers), Schizophrenia research and treatment (4 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). G. Schönbeck collaborates with scholars based in Austria and Belgium. G. Schönbeck's co-authors include H.N. Aschauer, Manfred Karobath, Gerhard Langer, Günther Sperk, K. Meszaros, Ulrike Willinger, Gabriele Fischer, Julius Neumark, Franz Resch and E. Lenzinger and has published in prestigious journals such as Biological Psychiatry, Annals of the New York Academy of Sciences and European Journal of Pharmacology.

In The Last Decade

G. Schönbeck

19 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Schönbeck Austria 9 123 75 67 62 53 19 325
Rajesh C. Shrotriya United States 12 218 1.8× 60 0.8× 128 1.9× 110 1.8× 102 1.9× 16 560
Susan E. Best United States 9 256 2.1× 37 0.5× 39 0.6× 80 1.3× 71 1.3× 12 396
Markus M. N�then Germany 12 292 2.4× 127 1.7× 49 0.7× 149 2.4× 161 3.0× 14 621
E. M. Goodall United Kingdom 8 182 1.5× 65 0.9× 144 2.1× 77 1.2× 62 1.2× 11 416
B P Riley United Kingdom 6 149 1.2× 50 0.7× 36 0.5× 89 1.4× 134 2.5× 11 406
Faiq A. Hameedi United States 10 251 2.0× 48 0.6× 104 1.6× 78 1.3× 65 1.2× 11 393
B.I. Diamond United States 11 129 1.0× 177 2.4× 99 1.5× 287 4.6× 83 1.6× 23 613
Maria Liu-Dumaw United States 6 122 1.0× 155 2.1× 170 2.5× 164 2.6× 85 1.6× 8 573
Joseph E. Comaty United States 13 98 0.8× 66 0.9× 46 0.7× 177 2.9× 55 1.0× 28 430
Janette McGaugh United States 6 154 1.3× 30 0.4× 36 0.5× 34 0.5× 37 0.7× 13 304

Countries citing papers authored by G. Schönbeck

Since Specialization
Citations

This map shows the geographic impact of G. Schönbeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Schönbeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Schönbeck more than expected).

Fields of papers citing papers by G. Schönbeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Schönbeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Schönbeck. The network helps show where G. Schönbeck may publish in the future.

Co-authorship network of co-authors of G. Schönbeck

This figure shows the co-authorship network connecting the top 25 collaborators of G. Schönbeck. A scholar is included among the top collaborators of G. Schönbeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Schönbeck. G. Schönbeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lenzinger, E., K. Meszaros, Ulrike Willinger, et al.. (1999). Prevalence and relapse predicting value of Cloninger's alcoholism types. European Neuropsychopharmacology. 9. 344–344. 1 indexed citations
2.
Meszaros, K., E. Lenzinger, Kurt Hornik, et al.. (1999). The Tridimensional Personality Questionnaire as a Predictor of Relapse in Detoxified Alcohol Dependents. Alcoholism Clinical and Experimental Research. 23(3). 483–486. 71 indexed citations
3.
Meszaros, K., E. Lenzinger, Kurt Hornik, et al.. (1997). Biperiden and Haloperidol Plasma Levels and Extrapyramidal Side Effects in Schizophrenic Patients. Neuropsychobiology. 36(2). 69–72. 1 indexed citations
4.
Meszaros, K., E. Lenzinger, Ulrike Willinger, et al.. (1997). The tridimensional personality questionnaire as a predictor of relapse in detoxified alcohol dependents. Biological Psychiatry. 42(1). 34S–34S. 3 indexed citations
5.
Meszaros, K., Ulrike Willinger, Gabriele Fischer, G. Schönbeck, & H.N. Aschauer. (1996). The tridimensional personality model: Influencing variables in a sample of detoxified alcohol dependents. Comprehensive Psychiatry. 37(2). 109–114. 23 indexed citations
6.
Langer, Gerhard, Julius Neumark, B. Saletu, et al.. (1995). Isoflurane Narcotherapy in Depressive Patients Refractory to Conventional Antidepressant Drug Treatment. Neuropsychobiology. 31(4). 182–194. 37 indexed citations
7.
Schönbeck, G., et al.. (1991). [Serotonin and eating disorders].. PubMed. 62(3). 198–201. 3 indexed citations
8.
Møller, Henrik, Werner Kissling, Pierre Baumann, et al.. (1988). Non-Response to Antidepressants: Risk Factors and Therapeutic Possibilities. Pharmacopsychiatry. 21(6). 285–287. 6 indexed citations
9.
Aschauer, H.N., et al.. (1988). Plasma Concentrations of Haloperidol and Prolactin and Clinical Outcome in Acutely Psychotic Patients. Pharmacopsychiatry. 21(5). 246–251. 11 indexed citations
10.
Resch, Franz, et al.. (1988). [The function of lytic effector cells in schizophrenic patients].. PubMed. 100(12). 404–7. 3 indexed citations
11.
Aschauer, H.N., Franz Resch, G. Schönbeck, et al.. (1987). Natural Immunity in Schizophrenia. Annals of the New York Academy of Sciences. 496(1). 743–744. 2 indexed citations
12.
Langer, Gerhard, et al.. (1985). Rapid Psychotherapeutic Effects of Anesthesia with Isoflurane (ES Narcotherapy) in Treatment-Refractory Depressed Patients. Neuropsychobiology. 14(3). 118–120. 38 indexed citations
13.
Geenen, Vincent, Gerhard Langer, G. Schönbeck, et al.. (1985). Release of human neurophysin I during insulin-induced hypoglycemia in depressed patients is abolished after recovery with clomipramine treatment. Psychoneuroendocrinology. 10(1). 61–69. 4 indexed citations
14.
Langer, Gerhard, et al.. (1984). THE CONCEPT OF COMMON THERAPEUTIC MECHANISMS OF ANTIDEPRESSANT AND NEUROLEPTIC DRUGS. Clinical Neuropharmacology. 7. S84–S84. 1 indexed citations
15.
Langer, Gerhard, Franz Resch, H.N. Aschauer, et al.. (1984). TSH-Response Patterns to TRH Stimulation May Indicate Therapeutic Mechanisms of Antidepressant and Neuroleptic Drugs. Neuropsychobiology. 11(4). 213–218. 24 indexed citations
16.
Langer, Gerhard, et al.. (1983). The TSH-response to trh: a possible predictor of outcome to antidepressant and neuroleptic treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 7(2-3). 335–342. 20 indexed citations
17.
Langer, Gerhard, et al.. (1982). Neuroendocrine mechanisms in the therapeutic effects of antidepressant drugs: the "thyroid-axis" hypothesis.. PubMed. 32. 297–302. 1 indexed citations
18.
Placheta, P., et al.. (1979). Reduction of endogenous level, uptake and release of taurine after intrastriatal kainic acid injection. Neuropharmacology. 18(4). 399–402. 23 indexed citations
19.
Karobath, Manfred, Günther Sperk, & G. Schönbeck. (1978). Evidence for an endogenous factor interfering with 3H-diazepam binding to rat brain membranes. European Journal of Pharmacology. 49(3). 323–326. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rajesh C. Shrotriya Breakdown of academic impact, for papers by Susan E. Best Breakdown of academic impact, for papers by Markus M. N�then Breakdown of academic impact, for papers by E. M. Goodall Breakdown of academic impact, for papers by B P Riley Breakdown of academic impact, for papers by Faiq A. Hameedi Breakdown of academic impact, for papers by B.I. Diamond Breakdown of academic impact, for papers by Maria Liu-Dumaw Breakdown of academic impact, for papers by Joseph E. Comaty Breakdown of academic impact, for papers by Janette McGaugh
Rankless by CCL
2026